![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
September 21, 2006
Inhalable Infertility
Treatment (The Pharm Voice)
In her blog, Gloria Gamat reports on an agreement between Serono and Syntonix
Pharmaceuticals to collaborate on developing an inhalable follicle-stimulating
hormone therapy for treating infertility.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct